Self-Reported Impact of Osteogenesis Imperfecta (OI) on Quality of Life (QOL) Domains in Adults

Author(s)

Raggio C1, Wekre LL2, Bober MB3, Semler O4, Westerheim I5, Hart T6, van Welzenis T5, Hawthorne R7, Prince S7, Rauch F8
1Hospital for Special Surgery, New York, NY, USA, 2Sunnaas Rehabilitation Hospital, Bjørnemyr, Norway, 3Alfred I. duPont Hospital, Wilmington, NC, USA, 4University Hospital Cologne, Cologne, Germany, 5Osteogenesis Imperfecta Federation Europe, Heffen, Belgium, 6Osteogenesis Imperfecta Foundation, Gaithersburg, MD, USA, 7Wickenstones Ltd, Abingdon, LON, UK, 8McGill University Hospital, Montreal, QC, Canada

OBJECTIVES: The IMPACT Survey aimed to collect the most comprehensive self-reported dataset on OI, a rare hereditary connective tissue disorder associated with low bone mass, bone fragility and deformities, and variable secondary features, e.g. hearing loss and cardiac or pulmonary conditions. As few large datasets describe the experience of individuals with OI, the survey explored the impact of OI on QoL domains and worries of adults with OI.

METHODS: Together with the Osteogenesis Imperfecta Federation Europe and the Osteogenesis Imperfecta Foundation (USA) we have developed an international survey in eight languages. It was fielded online (July-September 2021) and aimed at adults (aged ≥18 years) or adolescents (aged ≥12–17 years) with OI, caregivers (with or without OI) of children or adults with OI and other close relatives; overall 2,278 individuals participated. Questions covered the patient healthcare journey, worries, impact on individuals, their families, and finances. Non-English language responses were translated into English. Data were cleaned, coded, and analysed using StataSE 17.0.

RESULTS: 1,291 adults with OI who were not caregivers for children with OI participated (69.8% female, mean age 40.8 years). They described their OI as mild (33.5%), moderate (47.0%) or severe (15.4%). In the past 12 months, respondents perceived any (very mild to severe) impact of OI on their leisure activities (84.0%), job choices (74.1%), social life (72.7%), happiness (69.9%), mental health (65.5%) and working hours (64.1%). Most participants experienced some level of worry about the impact of aging (91.9%), future fractures (88.7%), mobility loss (88.1%), additional OI complications (86.4%) and loss of ability to selfcare (83.4%).

CONCLUSIONS: Adults with OI are impacted by their condition across QoL domains and worry about its progression. Further analysis will elucidate the support needs of adults with OI and help to shape treatment, care, and policy making.

Conference/Value in Health Info

2022-11, ISPOR Europe 2022, Vienna, Austria

Value in Health, Volume 25, Issue 12S (December 2022)

Code

PCR60

Topic

Patient-Centered Research

Topic Subcategory

Patient-reported Outcomes & Quality of Life Outcomes

Disease

SDC: Injury & Trauma, SDC: Musculoskeletal Disorders (Arthritis, Bone Disorders, Osteoporosis, Other Musculoskeletal), SDC: Systemic Disorders/Conditions (Anesthesia, Auto-Immune Disorders (n.e.c.), Hematological Disorders (non-oncologic), Pain)

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×